Otsuka’s IV solutions subsidiary, Otsuka Pharmaceutical Factory, is breaking into the North American market with the help of ...

However, CEO Joe Almeida stressed that the earliest that new products could start to ship from the plant is late November.

Baxter, a health care solutions manufacturer headquartered in Illinois, has been making progress on reopening one of its ...

Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased updates in late November, mid-December and ...

Baxter International Inc.’s Marion plant is now producing a limited amount of IV solutions, the manufacturer said Thursday. Baxter has restarted production on the line that produces the largest ...

Most of Nashville's hospitals have a healthy supply of fluids, but they are continuing to assess sometimes daily and search ...

ICU Medical (NASDAQ:ICUI) and Otsuka Pharmaceutical Factory, a unit of Japan’s Otsuka, are launching a joint venture focused ...

The company has been trying to reinstate production at the plant, which makes 60% of the United States' supply of IV fluids and some key dialysis solutions, after it was closed in late September due ...

Baxter International cut its annual profit forecast on Friday due to a hurricane-related hit to its intravenous solutions facility, sending its shares down 3.3% in premarket trading.

While flooding in September halted production of intravenous solution bags at the Baxter International plant in Marion, N.C., chronic shortages of IV solutions, enteral formulas and other products are ...

Baxter International's Q3 2024 adjusted EPS of $0.80 beat estimates, driven by strong Medical Products & Therapies sales and ...

Otsuka Holdings will pay ICU Medical an upfront payment of $200 million. The U.S. IV products market has seen ...